Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 30, 2022 | Post-IPO Debt | $20M | 2 | HealthCare Royalty Partners | — | Detail |
Feb 24, 2022 | Post-IPO Debt | $27.50M | 1 | SLR Capital Partners | — | Detail |
May 21, 2018 | Post-IPO Debt | $50M | — | — | — | Detail |
Jul 18, 2016 | Post-IPO Equity | $110M | 10 | — | — | Detail |
Jun 22, 2015 | Post-IPO Equity | $77.77M | 7 | New Enterprise Associates | — | Detail |
Jun 20, 2014 | IPO | $60M | — | — | — | Detail |
Aug 31, 2011 | Series B | $30M | 3 | Amgen Ventures | — | Detail |
Nov 16, 2010 | Debt Financing | $5.01M | — | — | — | Detail |
Jun 12, 2008 | Series A | $26.09M | 1 | CMEA Capital | — | Detail |